First-in-human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety of GEN1046 in Subjects With Malignant Solid Tumors
Lung | Phase I | Breast | Cervix
What is the purpose of this trial?
The purpose of the trial is to evaluate the safety of GEN1046 in patients with malignant solid tumors
- Trial withGenmab, Inc.
- Start Date06/16/2022
- End Date06/01/2023
- Last Updated07/12/2022
- Study HIC#2000025194